Cena Rain by Virtuals

Enlivex (ENLV) is going through a difficult period as its share price continues to collapse, its Nasdaq listing comes under pressure, and its financial position raises growing concerns. Despite ongoing clinical progress, the company has struggled to restore confidence in its stock. Two reverse stock splits within a few months have failed to reverse the broader decline, leaving ENLV at a critical point in its market performance. As of November 2, the stock is trading around $1.78 to $1.82 after a sharp daily decline of approximately 29.92%. The broader trend remains firmly bearish, with ENLV continuing to form lower highs and lower lows. Buying interest has struggled to gain momentum, and the latest sell-off has pushed the stock deeper into record-low territory. The scale of the decline also needs to be considered alongside the company's recent corporate actions. Enlivex completed a 1-for-15 reverse stock split in July, followed by another 1-for-16 split on October 27. These adjustments reduced the number of outstanding shares and changed the historical price scale, meaning the decline from approximately $50 on the adjusted chart does not represent a straightforward fall from the original share price. Even after accounting for these changes, the stock's performance remains deeply negative. Nasdaq Delisting Concerns Add to the Pressure On October 27, Enlivex disclosed that Nasdaq had issued a delisting notice after the company failed to maintain the exchange's $1 minimum bid-price requirement for 30 consecutive business days. The situation is particularly challenging because Enlivex had already completed a reverse stock split within the previous 12 months. Reverse splits can temporarily lift a stock's quoted price, but they do not improve a company's financial position. They cannot generate revenue, increase cash reserves or resolve underlying business challenges. Enlivex's repeated reliance on this approach has yet to produce a lasting recovery, leaving its Nasdaq compliance in question. The possibility of delisting could also complicate future financing. A Nasdaq listing provides access to a broader pool of market participants and can make capital raising easier. Losing that advantage could increase financing costs and make it more difficult for Enlivex to secure the resources needed to advance its clinical programs. For a company that has yet to establish a commercially successful product, the implications extend beyond its share price. Its ability to finance future research is becoming increasingly important. Allocetra's Clinical Progress Faces a Financial Test Enlivex is directing its resources toward Allocetra, its investigational treatment for age-related knee osteoarthritis. On October 28, the company announced that 135 patients had been randomized in its Phase 2b clinical trial, with six-month topline data expected in mid-2027. Reaching this milestone represents meaningful progress for the clinical program. However, the timeline also highlights the financial commitment required to bring the research forward. With data still months away, Enlivex must maintain sufficient resources to support the trial while managing its broader financial challenges. The company announced a restructuring plan on October 19 that includes reducing its workforce by approximately 60%. The move reflects a shift toward prioritizing Allocetra while cutting operating expenses. Although the reduction could help conserve cash, it does not eliminate the need for additional financing. The central issue is whether Enlivex can sustain its clinical development without relying heavily on new capital. Issuing additional shares at depressed prices could significantly dilute existing shareholders, while difficulties securing funding could place further pressure on the clinical program. This financial uncertainty is a major reason why progress in Allocetra has not translated into a meaningful recovery in ENLV's share price. RAIN Treasury Raises Questions About Enlivex's Financial Strategy Enlivex's financial position also includes a substantial RAIN token treasury. The company was reported to hold approximately $567 million in RAIN tokens as of April 27, 2026. The reported value is substantial, but the treasury's actual financial strength depends on RAIN's market price and liquidity. Digital assets can experience sharp price swings, and a large token position may be difficult to sell without affecting the market. The value recorded on paper may therefore differ considerably from the amount Enlivex could realize through liquidation. In March, Boral Capital described Enlivex's debt offering and RAIN exposure as a strategically negative shift. The criticism reflects concerns about the company's financial direction and its growing exposure to digital assets. While the treasury could provide financial resources, it also introduces another layer of uncertainty into Enlivex's valuation. The company's clinical operations, financing structure and RAIN holdings now play interconnected roles in determining its financial outlook. The ability to convert those holdings into usable capital could become increasingly important as Enlivex works to fund Allocetra and address its Nasdaq compliance challenges. ENLV's Technical Structure Remains Bearish The technical picture continues to reflect the pressure surrounding the stock. On the daily and four-hour charts, ENLV has maintained a pattern of lower highs and lower lows, with the early-October price spike followed by a sharp reversal. The rebound attempts that followed have been relatively weak, suggesting that buyers have struggled to regain control. The latest sell-off pushed the stock below its previous 52-week low near $2.22. That level could now act as resistance rather than support. The $2.54 to $2.70 region also remains important, as it marks the area from which the latest breakdown developed. On the downside, $1.73 represents a recent low, but the chart offers limited historical support below that level. A break beneath it could leave ENLV vulnerable to further losses as traders search for a new price floor. Momentum indicators are also showing extreme weakness. Daily RSI readings between approximately 9 and 17 place the stock deep in oversold territory. While such conditions can lead to short-term rebounds, they can also persist during prolonged downtrends. A positive MACD histogram or a modest hourly bounce may indicate that selling pressure is easing, but neither is enough to confirm a sustained reversal. Liquidity adds another concern. Turnover of approximately $248,600 points to relatively limited trading activity, which can amplify price movements and make it harder for buying interest to establish a lasting recovery. The latest 30% decline has not been tied to a clearly confirmed single catalyst. However, the combination of Nasdaq uncertainty, repeated reverse splits, restructuring and financing concerns has created an environment in which the stock remains vulnerable to further selling. What Could Trigger a Recovery? A successful Nasdaq appeal, improved financing visibility or meaningful progress in the Allocetra trial could help restore some confidence in Enlivex. These developments would address several of the concerns weighing on the company and could provide a foundation for a more sustained recovery. On the other hand, continued weakness in the share price, additional financing needs or further listing complications could prolong the downturn. From a technical perspective, a sustained move above $1.90 would offer an early indication that buyers are beginning to regain control. A recovery through the $2.08 to $2.20 region on stronger volume would provide additional evidence of improving momentum. A daily close above $2.70 with expanding volume would represent a more meaningful shift in the broader technical structure. Still, Enlivex's financial position remains the more important factor. Greater clarity on its Nasdaq appeal, available cash, RAIN treasury exposure and the funding required to complete the Allocetra trial could have a greater impact on its long-term outlook than any short-term price movement. Enlivex's clinical progress provides a potential source of future value, but the company is facing financial and listing challenges that remain unresolved. Until those concerns begin to ease, the stock's deeply oversold condition may offer room for a rebound without guaranteeing a lasting recovery. $ENLV

$GRVT Crypto markets saw a volatile week. Geopolitical tensions and economic uncertainty weighed on sentiment. Bitcoin and major altcoins faced selling pressure, while liquidations added to the swings. However, some altcoins stood out as exceptions, posting strong gains moving closer to recovering their October losses. Weekly winners Starknet [$STRK] – A Layer-2 scaling network posted a strong double-digit rally Starknet [$STRK] led this week’s gainers with an 88% increase, propelling the token to the $0.12 high. The rally has brought $STRK back to levels last seen in late Q4 2025, putting it closer to recovering the losses from the October crash, when the token peaked near $0.30. Technically, this means that long-term investors who bought before the crash are close to breakeven and ready to cash out. On the other hand, the rally has driven the RSI to overbought levels, increasing the likelihood of a pullback. As the weekly chart shows, $STRK’s RSI has climbed much higher than the level it hit during the Q4 rally. According to technical analysis, this means that the price is at risk of cooling if the buying pressure subsides. That said, the daily chart hasn’t shown signs of cooling down yet. The situation can be interpreted as a positive sign, which means that buyers are still in control of the situation, and FOMO isn’t gone yet, despite the fact that the daily RSI is already in the overbought region. According to AMBCrypto, this divergence is a sign that while weekly RSI might suggest that $STRK is due for a short-term selloff, strong daily momentum could absorb the pressure and cause liquidity sweeps. If buyers continue to push, $STRK could be set up for a short squeeze with $0.15 as a possible target. Bitway [$BTW] – Crypto project reinforced bullish conviction over the week Bitway [$BTW] was the second-largest weekly winner, climbing 35% and nearing the $1.70 mark. The token is on track to close the week at another all-time high, but $1.70 could be a crucial resistance level to keep an eye on. Notably, the daily chart has not shown any cooling-off period even after the rally. In fact, $BTW has managed to register 10 consecutive weekly green candles, and every dip on the daily chart has attracted buying interest. So, both the price and the trading volumes remain bullish, which could lure more buyers into the fray. Consequently, if $BTW breaks above $1.70, the next target could be around $2. However, after such a strong rally, some traders may take profits. Nevertheless, as long as buyers continue to step in on dips, the bullish trend could continue. Aerodrome Finance [$AERO] – Decentralized exchange staged a strong recovery Aerodrome Finance [$AERO] took third place among this week’s gainers, climbing by 11%. While the rally is inferior to $STRK’s and $BTW’s, $AERO’s chart looks relatively stronger. The RSI indicator is in the high range, but continued buying pressure and FOMO may trigger another jump. On a daily chart, $AERO has managed to move past the mid-September resistance near $0.92 and is now approaching the $1 mark. The weekly RSI has also not hit the overbought level as $STRK did, which leaves a possibility for further gains. If the buy wall manages to get $AERO past $1, the rally could continue. Meanwhile, should the token fail to break above this level, there is a possibility of some profit-taking and a short-term cooldown. Weekly losers Venice Token [$VVV] – Native token of the ecosystem entered a cooldown phase Venice Token [$VVV] was the biggest loser this week with a 25% drop. After seven consecutive winning sessions that propelled the asset to a record $35, this bearish turn could either be a shallow correction or a sign of a deeper selloff. For the time being, however, the chart looks more like a shallow correction than a beginning of the end. As can be seen in the chart below, the weekly close printed by $VVV this week erased all the gains made during the prior week, marking the first red weekly candle in over a month. Meanwhile, the RSI has cooled off from overbought territory while the price has been ranging within a tight channel over the last two days. Technically, this development suggests bullish momentum has slowed down, but buyers are still in control. If $VVV manages to hold support, the correction could remain shallow. Sky [$SKY] – Governance token saw bears regain control over the week Sky [$SKY] was the second-biggest loser this week, shedding 17%. Interestingly, its daily and weekly charts resemble to that of $VVV, suggesting that this is more of a cooldown than the beginning of a deeper sell-off. The rally was coming after several weeks of gains and marked the first correction since the beginning of the rally in Q2 2026. The weekly RSI had also entered the overbought territory, so it is not surprising that it corrected. Meanwhile, $SKY is trading in a tight range on the daily chart, which suggests that the buyers are trying to hold their ground. However, the next test awaits as $SKY is approaching the resistance area it was facing in Q2. If the buyers manage to hold the support and resume the uptrend, the correction will be shallow. Otherwise, the bearish pressure may intensify. Rain [$RAIN] – Blockchain project reinforced its bearish structure over the week Rain [$RAIN] registered as the third-largest weekly loser, posting an 8% drop. While it underperformed the double-digit declines posted by $VVV and $SKY, its weekly performance remains the worst among the three. Technically, the weekly fall comes on the back of six consecutive weeks of losses, with the prior five weekly declines averaging nearly 6%. As such, the recent sell-off appears to be more of a strategic distribution than one wave of panic selling. Meanwhile, buyers have been unable to muster sufficient buying pressure to absorb the supply, with the overall trend remaining bearish on the weekly timeframe. As such, the path of least resistance for $RAIN is lower, with the decline below the important $0.01 threshold highly likely. Other notable losers In the broader market, downside volatility hit hard. Mina Protocol [MINA] led the losers with a 47% drop, followed by Capricorn [APR] falling 44%, and Chump Coin [CHUMP] slipping 43% as bearish momentum intensified. Conclusion This week was a rollercoaster. Big pumps, sharp dips, and nonstop action. As always, stay sharp, do your own research, and trade smart.

$GRVT Crypto Market Rebounds After Macro-Driven Dip The cryptocurrency market ended a volatile week nearly flat, recovering from a Sept. 29 slump that erased $50 billion in value before a late-week rally driven by “Uptober” sentiment. The initial downturn, which briefly knocked aggregate market capitalization down to $2.95 trillion, coincided with surging oil prices and rising Treasury yields. Bitcoin led the broader market’s wild swings, closing September up 7% and narrowing its year-to-date losses to 4%. After dipping below $83,000 on Monday, the asset held above that support level until Wednesday, when a brief spike to $85,300 quickly surrendered its gains. The start of October offered a glimpse into how bitcoin might perform in a month known historically for strong returns. Market data showed bitcoin surging to $87,217 on Oct. 2, matching levels not seen since Sept. 23. However, the top cryptocurrency quickly surrendered those gains, sliding to $84,250, just below its weekly open of $84,720. A weekend rebound pushed bitcoin’s price up over $1,200 to close at $85,500, securing a modest weekly gain of nearly 1% and carrying its market cap just past $1.7 trillion. Major Altcoins Trade Sideways as Ether Gains 0.4% Bitcoin’s range-bound price action extended across high-cap altcoins, most of which turned in even flatter weekly performances. Ether ($ETH) tracked bitcoin almost step-for-step, bottoming on Sept. 28 before rallying to a Thursday high of $2,754. A swift sell-off followed, but $ETH steadily clawed its way back to $2,700. By Sunday afternoon (3:45 p.m. EST), $ETH was trading just over $2,700, up 0.4% for the week. BNB, meanwhile, was one of a handful of high-cap altcoins with weekly gains in excess of 1%, rising from $778 to $789. Quant (QUANT) and hedera (HBAR) were among the few notable altcoins with impressive gains, jumping 39% and 9%, respectively. Meanwhile, privacy coin zcash (ZEC), one of the best-performing high-cap altcoins in September, closed the week down 17% after plunging from just over $1,600 to $1,332 on Sunday. Other altcoins that logged significant losses included rain (RAIN), down approximately 9%; near (NEAR), down 8.6%; and uniswap (UNI), down 7.3%. Bitcoin cash ($BCH), which spiked weeks ago following news of a CME $BCH futures announcement, closed down 5.2%. The mixed altcoin price action dragged their aggregate market cap down from $1.3 trillion at the start of the week to $1.285 trillion by Sunday.

Crypto is showing mixed momentum while precious metals and crude oil continue to react to macroeconomic developments. From Bitcoin’s market leadership to altcoin volatility, traders are watching where capital moves next. Here’s your latest market snapshot for October 3, 2026. ━━━━━━━━━━━━━━━━━━ 🚀 TOP CRYPTO GAINERS — MOMENTUM WATCH The strongest reported 24-hour performers include: 🟢 $SAND — +58.52% 🟢 $LCX — +21.83% 🟢 $MDT — +18.71% 🟢 $MANA — +13.77% 🟢 $ATH — +13.27% Additional movers: $WLD +12.88%, $APE +12.49%, $CT +12.12%, $MPLX +11.38%, and $MINA +10.37%. Gaming, metaverse, and smaller-cap tokens are attracting attention, but sharp percentage gains should always be assessed alongside liquidity and trading volume. ━━━━━━━━━━━━━━━━━━ 🔻 TOP CRYPTO LOSERS — DOWNSIDE PRESSURE The reported weakest performers include: 🔴 $RAIN — -17.88% 🔴 $LIGHTER — -7.55% 🔴 $GRAM — -5.26% These declines highlight the importance of monitoring market depth, volatility, and support levels before interpreting a move as a broader trend. ━━━━━━━━━━━━━━━━━━ 💎 TOP 5 MARKET-CAP CRYPTO ASSETS ₿ $BTC — Bitcoin The benchmark for crypto market direction, liquidity, and institutional sentiment. ♦️ $ETH — Ethereum A major smart-contract ecosystem with exposure to DeFi, tokenization, and network activity. 💵 $USDT — Tether The leading stablecoin used extensively for crypto liquidity and trading pairs. 🟡 $BNB — BNB The Binance ecosystem asset, with utility across its blockchain and exchange services. ⚡ $XRP — XRP A major digital asset closely watched for payment-network adoption and market momentum. Also keeping $SOL — Solana on the radar for high-beta momentum and ecosystem activity. ━━━━━━━━━━━━━━━━━━ 🥇 COMMODITIES RADAR — GOLD, SILVER & CRUDE OIL Precious metals and energy markets remain important macro indicators. 🟡 $XAU — GOLD Around $4,135/oz | -1.12% ⚪ $XAG — SILVER Around $60.36/oz | -1.30% 🛢️ $BZ — BRENT CRUDE Around $101.88/barrel | +0.36% 🛢️ $CL — WTI CRUDE Around $91.38/barrel | -1.75% Gold and silver closed lower in the reported snapshot, while Brent and WTI showed divergent performance. Energy-price movements remain relevant to inflation expectations, bond yields, and central-bank policy. ━━━━━━━━━━━━━━━━━━ 📊 THE BIGGER MARKET PICTURE Three developments deserve attention: 1️⃣ Crypto rotation: Strong gains in selected altcoins are creating opportunities to monitor relative strength, but isolated rallies do not automatically confirm a broad altseason. 2️⃣ Macro sensitivity: Gold, silver, and crude oil remain connected to inflation expectations, the US dollar, Treasury yields, and geopolitical developments. 3️⃣ Liquidity over hype: Bitcoin and Ethereum remain important market benchmarks, while altcoin participation and trading volume help reveal whether momentum is spreading. 🎯 MY MARKET WATCHLIST $BTC | $ETH | $SOL | $XRP | $BNB $USDT | $SAND | $LCX | $MDT | $MANA $ATH | $WLD | $APE | $CT | $MPLX $MINA | $RAIN | $LIGHTER | $GRAM $XAU | $XAG | $BZ | $CL The next move is not just about which asset rises the most. It is about identifying where liquidity, participation, and sustained momentum are developing. Trade the structure. Respect volatility. Let the market confirm the move. 📈 #CryptoMarket #Bitcoin #Ethereum #Altcoins #TopGainers #TopLosers #Gold #Silver #BrentCrude #WTI #MarketAnalysis #CryptoTrading #BTC #ETH #SOL #XRP #BNB